Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.

Leyland-Jones, Brian

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Sep 2005 - 5960-72 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0732-183X

10.1200/JCO.2005.06.150 doi


Adult
Aged
Aged, 80 and over
Anemia
Breast Neoplasms--drug therapy
Epoetin Alfa
Erythropoietin--adverse effects
Female
Hematinics--adverse effects
Hemoglobins--analysis
Humans
Injections, Subcutaneous
Middle Aged
Neoplasm Metastasis
Placebos
Quality of Life
Recombinant Proteins
Survival Analysis